GADD45alpha mediates arsenite-induced cell apoptotic effect in human hepatoma cells via JNKs/AP-1-dependent pathway

Ming Gao1, Wen Dong, Meiru Hu

  • 1Department of Cellular Immunology, Beijing Institute of Basic Medical Sciences, 27 Taiping Road, Beijing 100850, PR China.

Insights

Arsenite (As(III)) selectively induces apoptosis in hepatoma cells by activating the GADD45alpha/JNKs/AP-1 pathway. This mechanism offers a promising therapeutic strategy for hepatoma and other solid tumors, sparing normal liver cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Hepatocellular Carcinoma Research

Background:

  • Arsenite (As(III)) is an established chemotherapeutic agent for hematological malignancies like acute promyelocytic leukemia (APL) and multiple myeloma (MM).
  • The precise molecular mechanisms underlying arsenite's cytotoxicity in solid tumors, including hepatoma, remain incompletely understood.
  • Investigating arsenite's effects on normal versus cancerous liver cells is crucial for understanding its therapeutic potential and limitations.

Purpose of the Study:

  • To elucidate the molecular basis of arsenite-induced cytotoxicity in HepG2 human hepatoma cells.
  • To investigate the role of the GADD45alpha/JNKs/AP-1 pathway in arsenite's apoptotic effects.
  • To determine if arsenite exhibits selective toxicity towards hepatoma cells compared to normal hepatic cells.

Main Methods:

  • Exposure of HepG2 human hepatoma cells and HL7702 human diploid hepatic cells to arsenite (As(III)).
  • Analysis of GADD45alpha induction and subsequent activation of the JNKs/AP-1 signaling pathway.
  • Comparative assessment of arsenite-induced apoptosis in cancer versus normal cells.

Main Results:

  • Arsenite effectively induced apoptosis in HepG2 hepatoma cells.
  • This apoptotic response was mediated by GADD45alpha induction and activation of the JNKs/AP-1 cell death pathway.
  • Similar GADD45alpha/JNKs/AP-1 pathway activation and significant apoptosis were not observed in normal HL7702 hepatic cells.
  • Demonstrated selective pro-apoptotic activity of arsenite in hepatoma cells.

Conclusions:

  • Arsenite selectively triggers apoptosis in hepatoma cells via the GADD45alpha-dependent cell death pathway.
  • The GADD45alpha/JNKs/AP-1 pathway is a key mediator of arsenite's anti-cancer effects in hepatoma.
  • Targeting strategies to up-regulate GADD45alpha may enhance arsenite's efficacy in treating hepatoma and other solid tumors.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...